Sarah A Eisenstein1, William B Dewispelaere2, Meghan C Campbell3, Heather M Lugar1, Joel S Perlmutter4, Kevin J Black5, Tamara Hershey6. 1. Department of Psychiatry, Washington University in St. Louis, St. Louis, MO, USA. 2. College of Arts and Sciences, Washington University in St. Louis, St. Louis, MO, USA. 3. Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA; Department of Radiology, Washington University in St. Louis, St. Louis, MO, USA. 4. Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA; Department of Radiology, Washington University in St. Louis, St. Louis, MO, USA; Department of Anatomy & Neurobiology, Washington University in St. Louis, St. Louis, MO, USA; Division of Biology and Biomedical Sciences, Washington University in St. Louis, St. Louis, MO, USA; Programs in Physical Therapy and Occupational Therapy, Washington University in St. Louis, St. Louis, MO, USA. 5. Department of Psychiatry, Washington University in St. Louis, St. Louis, MO, USA; Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA; Department of Radiology, Washington University in St. Louis, St. Louis, MO, USA; Department of Anatomy & Neurobiology, Washington University in St. Louis, St. Louis, MO, USA; Division of Biology and Biomedical Sciences, Washington University in St. Louis, St. Louis, MO, USA. 6. Department of Psychiatry, Washington University in St. Louis, St. Louis, MO, USA; Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA; Department of Radiology, Washington University in St. Louis, St. Louis, MO, USA; Division of Biology and Biomedical Sciences, Washington University in St. Louis, St. Louis, MO, USA. Electronic address: tammy@wustl.edu.
Abstract
BACKGROUND: Deep brain stimulation of the subthalamic nucleus (STN DBS) reduces Parkinson disease (PD) motor symptoms but has unexplained, variable effects on mood. OBJECTIVE: The study tested the hypothesis that pre-existing mood and/or anxiety disorders or increased symptom severity negatively affects mood response to STN DBS. METHODS: Thirty-eight PD participants with bilateral STN DBS and on PD medications were interviewed with Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID) and completed Beck Depression Inventory (BDI) and Spielberger State Anxiety Inventory (SSAI) self-reports. Subsequently, during OFF and optimal ON (clinical settings) STN DBS conditions and while off PD medications, motor function was assessed with the United Parkinson Disease Rating Scale (UPDRS, part III), and participants rated their mood with Visual Analogue Scales (VAS), and again completed SSAI. VAS mood variables included anxiety, apathy, valence and emotional arousal. RESULTS: STN DBS improved UPDRS scores and mood. Unexpectedly, PD participants diagnosed with current anxiety or mood disorders experienced greater STN DBS-induced improvement in mood than those diagnosed with remitted disorders or who were deemed as having never met threshold criteria for diagnosis. BDI and SSAI scores did not modulate mood response to STN DBS, indicating that clinical categorical diagnosis better differentiates mood response to STN DBS than self-rated symptom severity. SCID diagnosis, BDI and SSAI scores did not modulate motor response to STN DBS. CONCLUSIONS: PD participants diagnosed with current mood or anxiety disorders are more sensitive to STN DBS-induced effects on mood, possibly indicating altered basal ganglia circuitry in this group.
BACKGROUND: Deep brain stimulation of the subthalamic nucleus (STNDBS) reduces Parkinson disease (PD) motor symptoms but has unexplained, variable effects on mood. OBJECTIVE: The study tested the hypothesis that pre-existing mood and/or anxiety disorders or increased symptom severity negatively affects mood response to STNDBS. METHODS: Thirty-eight PDparticipants with bilateral STNDBS and on PD medications were interviewed with Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID) and completed Beck Depression Inventory (BDI) and Spielberger State Anxiety Inventory (SSAI) self-reports. Subsequently, during OFF and optimal ON (clinical settings) STNDBS conditions and while off PD medications, motor function was assessed with the United Parkinson Disease Rating Scale (UPDRS, part III), and participants rated their mood with Visual Analogue Scales (VAS), and again completed SSAI. VAS mood variables included anxiety, apathy, valence and emotional arousal. RESULTS:STNDBS improved UPDRS scores and mood. Unexpectedly, PDparticipants diagnosed with current anxiety or mood disorders experienced greater STNDBS-induced improvement in mood than those diagnosed with remitted disorders or who were deemed as having never met threshold criteria for diagnosis. BDI and SSAI scores did not modulate mood response to STNDBS, indicating that clinical categorical diagnosis better differentiates mood response to STNDBS than self-rated symptom severity. SCID diagnosis, BDI and SSAI scores did not modulate motor response to STNDBS. CONCLUSIONS:PDparticipants diagnosed with current mood or anxiety disorders are more sensitive to STNDBS-induced effects on mood, possibly indicating altered basal ganglia circuitry in this group.
Authors: Sidney H Kennedy; Peter Giacobbe; Sakina J Rizvi; Franca M Placenza; Yasunori Nishikawa; Helen S Mayberg; Andres M Lozano Journal: Am J Psychiatry Date: 2011-02-01 Impact factor: 18.112
Authors: Meghan C Campbell; Kevin J Black; Patrick M Weaver; Heather M Lugar; Tom O Videen; Samer D Tabbal; Morvarid Karimi; Joel S Perlmutter; Tamara Hershey Journal: J Neuropsychiatry Clin Neurosci Date: 2012 Impact factor: 2.198
Authors: J L Houeto; V Mesnage; L Mallet; B Pillon; M Gargiulo; S Tezenas du Moncel; A M Bonnet; B Pidoux; D Dormont; P Cornu; Y Agid Journal: J Neurol Neurosurg Psychiatry Date: 2002-06 Impact factor: 10.154
Authors: Samer D Tabbal; Fredy J Revilla; Jonathan W Mink; Patricia Schneider-Gibson; Angela R Wernle; Gabriel A de Erausquin; Joel S Perlmutter; Keith M Rich; Joshua L Dowling Journal: Neurosurgery Date: 2007-09 Impact factor: 4.654
Authors: Ian H Kratter; Ahmed Jorge; Michael T Feyder; Ashley C Whiteman; Yue-Fang Chang; Luke C Henry; Jordan F Karp; R Mark Richardson Journal: Transl Psychiatry Date: 2022-05-27 Impact factor: 7.989
Authors: Mikhail Milchenko; Scott A Norris; Kathleen Poston; Meghan C Campbell; Mwiza Ushe; Joel S Perlmutter; Abraham Z Snyder Journal: J Med Imaging (Bellingham) Date: 2018-01-08
Authors: Andres M Lozano; Nir Lipsman; Hagai Bergman; Peter Brown; Stephan Chabardes; Jin Woo Chang; Keith Matthews; Cameron C McIntyre; Thomas E Schlaepfer; Michael Schulder; Yasin Temel; Jens Volkmann; Joachim K Krauss Journal: Nat Rev Neurol Date: 2019-03 Impact factor: 42.937
Authors: Amritha Gourisankar; Sarah A Eisenstein; Nicholas T Trapp; Jonathan M Koller; Meghan C Campbell; Mwiza Ushe; Joel S Perlmutter; Tamara Hershey; Kevin J Black Journal: R Soc Open Sci Date: 2018-07-18 Impact factor: 2.963